Information Library

Results for: Cardiovascular - Europe

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • The Contribution of Early-phase Clinical Data to a Drug’s Integrated Cardiac Safety Portfolio

    Hear from the Experts — December 6, 2011
    This article examines the financial and time benefits to incorporating intensive ECG and QT/QTc monitoring in early-phase clinical studies.

  • Constant Vigilance

    Case Study — March 16, 2011
    Centralized planning played a key role in improving productivity during site visits and close monitoring ensured the high standards Quintiles put in place were met.

  • A Lock on Consistency

    Case Study — February 1, 2011
    A double-blind, randomized, placebo-controlled trial evaluating the safety and efficacy of eplerenone in patients with heart failure following acute myocardial infarction.

  • Acute Coronary Syndrome - Tailored Solutions

    Case Study — February 1, 2011
    Find out how our experience in multi-national cardiovascular clinical trials helped this customer reach database lock 66 days after LPO.

  • Quintiles Speeds Early-Phase Decision Making with New Unit in Hyderabad, India

    Press Release — January 24, 2011 – Quintiles officially opened its new Phase I research facility in Hyderabad, India at Apollo Health City.

  • Exceptional Flexibility

    Case Study — December 17, 2010
    Quintiles' best-in-class sales training capabilities, therapeutic expertise and established local relationships meant 3 key brands maintained share of voice in Spain.

  • Site Performance - Swifter, Higher, Stronger

    Presentation — November 2, 2010
    SarahJane McIntyre's presentation "Site Performance - Swifter, Higher, Stronger" at AusBiotech 2010

  • NHS Motivating Patients

    Case Study — May 7, 2010
    In 2008, the NHS announced plans to offer free health checks for heart disease, stroke, diabetes and kidney disease. Learn why Quintiles was the right ally for the NHS to successfully launch this cardio risk assessment program.

  • Commercial – Identify, Promote and Prove Treatment Value

    Brochure — April 1, 2010
    Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success.

  • New FDA Guidance on Antidiabetic Therapies

    White Paper — December 11, 2009
    Understanding the FDA Guidance on Assessing Cardiovascular Risks for new Antidiabetic Therapies. Learn what FDA cardiac safety requirements may mean for your development program.

Page 1 of 2 (11 results)

Subscribe to Email Based on Your Interests

Set preferences